Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation
Background: Plecanatide, with the exception of a single amino acid replacement, is identical to human uroguanylin and is approved in the United States for adults with chronic idiopathic constipation (CIC). This double-blind, placebo-controlled, phase III study evaluated the efficacy and safety of pl...
Main Authors: | Michael DeMicco, Laura Barrow, Bernadette Hickey, Kunwar Shailubhai, Patrick Griffin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-11-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756283X17734697 |
Similar Items
-
Clinical utility of plecanatide in the treatment of chronic idiopathic constipation
by: Islam BN, et al.
Published: (2018-08-01) -
Plecanatide: a new guanylate cyclase agonist for the treatment of chronic idiopathic constipation
by: Satish S.C. Rao
Published: (2018-06-01) -
Profile of plecanatide in the treatment of chronic idiopathic constipation: design, development, and place in therapy
by: Sharma A, et al.
Published: (2019-01-01) -
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.
by: Brian E Lacy, et al.
Published: (2015-01-01) -
Safety of polyethylene glycol 3350 solution in chronic constipation: randomized, placebo-controlled trial
by: McGraw T
Published: (2016-07-01)